Experienced life science communications professional dedicated to developing strategies uniquely tailored to client needs, delivering clear messages and content through investor and public relations channels. Former specialty pharmaceutical analyst with more than 12 years financial experience, including five years on Wall Street. Knowledgeable in the investment process and multiple methods of company valuation. Strong ability and history of building lasting relationships with key company executives as well as buy-side investors with the ability to translate and distill complex investment stories to concise and impactful messaging.